Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Estradot
Active Ingredient: Oestradiol hemihydrate 0.39mg equivalent to oestradiol 25Ág/24hour
Dosage Form: Transdermal patch, systemic effect
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Noven Pharmaceuticals Inc, Miami, Florida, United States of America
Product: Lisinopril
Active Ingredient: Lisinopril dihydrate equivalent to 10mg lisinopril
Dosage Form: Tablet
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer: Delta Limited, Hafnarfjordur, Iceland
Product: Lisinopril
Active Ingredient: Lisinopril dihydrate equivalent to 20mg lisinopril
Dosage Form: Tablet
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer: Delta Limited, Hafnarfjordur, Iceland
Dated this 12th day of March 2003.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).